Archive for the ‘china retractions’ Category
An investigation at the Queensland University of Technology in Australia has found that a paper on air pollution and human health contains a host of issues with the data and its analysis. The paper has been retracted with a very detailed note from Environmental Research.
The issues with the paper include an “incorrect analysis of the data,” and its failure to properly cite multiple papers and one researcher’s contributions. Ultimately, according to the retraction note, the investigation found that the “conclusions of the paper are flawed.”
“Submicrometer particles and their effects on the association between air temperature and mortality in Brisbane, Australia” has been cited three times, according to Thomson Scientific’s Web of Knowledge.
The retraction note is very, very detailed. It outlines the problems with the paper:
The articles, published online earlier this year, recently received an expression of concern after the journal realized the guest editor David Gao, at the Federation University Australia, had coordinated the peer-review process. This was a major no-no, since Gao was also an author of 11 of the 13 papers. Mathematics and Mechanics of Solids slated the articles to be peer reviewed again, by reviewers not chosen by Gao.
Gao told us what happened next, from his perspective — he changed his mind about publishing the papers in MMS:
The authors of a paper on an anti-fungal bacterium couldn’t ward off a very common problem: plagiarism. The people credited on the paper, published in Applied Microbiology and Biotechnology, apparently weren’t the original authors, according to the retraction note.
We’re not sure who the original authors are. The retraction note doesn’t elaborate much:
The authors of a paper on a mechanism for potential cancer therapies are retracting it after realizing they published some proprietary findings “without permission and agreement from St. Jude Children’s Research Hospital.”
According to the retraction note in Journal of the American Chemical Society, the authors included an X-ray crystal structure and data that were gathered at St. Jude’s and considered the hospital’s intellectual property. On the paper, the last author, Zhengding Su, listed an affiliation at St. Jude and Hubei University of Technology in China, along with Amersino Biodevelop Inc., based in Waterloo, Canada.
A study on the cellular interactions underlying prostate cancer has been retracted after a whistleblower pointed out duplicated images in one of the paper’s figures that were “erroneously presented as unique.”
The International Journal of Cancer posted the notice in June. The authors backed the paper’s conclusions but agreed, “the most responsible course of action is to retract.”
The notice reads:
Thirteen papers in Mathematics and Mechanics of Solids now have an expression of concern, after it came to light that an author on most of the papers coordinated the peer-review process.
David Y. Gao, a well-known and prolific mathematician at the Federation University Australia, is the author of 11 of the papers, and also the guest editor of the special issue in which they were set to appear. The papers were published online earlier this year.
A spokesperson for SAGE, which publishes the journal, confirmed that the publisher decided to re-review the papers after learning about Gao’s role in the peer-review process:
The authors write that despite the corrections, “the results and conclusions put forth in the article remain unchanged.”
The paper, “TMEFF2 Deregulation Contributes to Gastric Carcinogenesis and Indicates Poor Survival Outcome” explored the role of TMEFF2 in gastric cancer. The researchers found that the protein acts as a tumor suppressor, and low levels can indicate the presence of cancerous cells.
Here’s the full correction notice, published by Clinical Cancer Research in August:
We don’t usually see both copies of a duplicated paper retracted, but this is a somewhat unusual case. In November 2011, a group of authors submitted the paper to Gynecologic Oncology. But two months’ prior, the first author had decided to also submit the paper to the Journal of Cellular Physiology, without listing three of the other researchers, including the primary author on the paper. It was published by the Journal of Cellular Physiology first, then by Gynecologic Oncology, both in July, 2012.
Jie Chen, first author on both articles, “takes full responsibility for the dual submission” and “other co-authors should be exempted from all responsibilities,” as the retraction notice from Gynecologic Oncology explains.
The corresponding author for both papers, Hung-Chuan Pan of Taichung Veterans General Hospital, had contacted the journal about publishing an erratum for one of the articles when the journal was tipped off by an email pointing out deeper problems in the two retracted papers.
The tipster provided evidence that alleged “a violation of ethics on the part of the authors,” according to the communications manager at the JNS Publishing Group, Jo Ann Eliason.
Both retraction notices, published October 2, detailed a number of “similarities” and “overlaps” in the papers.
A paper about the molecular details of lung cancer is being retracted for repeating datasets and “careless errors” in a pair of figures.
According to the note, the editor of Carcinogenesis wouldn’t have known about the problems if he hadn’t been tipped off that the paper by first author, XiaoJuan Sun — a researcher at Shenzhen Second People’s Hospital in China — shared “significant similarities” with another one of Sun’s papers that was retracted years ago. After the journal investigated the paper, it discovered that the authors had reported the same data as in the retracted paper “without significant additions or amendments,” along with some errors and inconsistencies.
Here’s the detailed note for “The EDA-containing cellular fibronectin induces epithelial mesenchymal transition in lung cancer cells through integrin α9β1-mediated activation of PI3-K /Akt and Erk1/2:”